Geode Capital Management, LLC Plus Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.27 - $0.48 $784 - $1,393	-2,904 Reduced 1.13%	255,148 $73,000
Q4 2022 Feb 13, 2023	SELL	$0.3 - $8.4 $115 - $3,234	-385 Reduced 0.15%	258,052 $81,000
Q3 2021 Nov 12, 2021	BUY	$1.83 - $2.46 $233,588 - $314,004	127,644 Added 97.59%	258,437 $493,000
Q2 2021 Aug 13, 2021	BUY	$2.0 - $2.89 $261,586 - $377,991	130,793 New	130,793 $334,000

Ticker PSTV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,601,400
Market Cap $45.7M
Description
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, lep...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.